secwatch.observer — SEC 8-K summary
======================================

Issuer:     Skye Bioscience, Inc. (SKYE)
CIK:        0001516551
Form:       8-K
Filed at:   2025-02-26T23:59:59+00:00
Accession:  0001516551-25-000002
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Skye Bioscience board approves amended inducement equity plan with broader change-in-control authority
--------------------------------------------------------------------------------

- Amendment gives administrator broader authority to cancel, assume, accelerate, or cash out outstanding awards upon a Change in Control.
- Total shares authorized under the plan remain 600,000; no change to share pool.
- Plan is used for inducement grants to new employees; all awards must be approved by a majority of independent directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1516551/000151655125000002/0001516551-25-000002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1516551/000151655125000002/skye-20250224.htm
  HTML page:      https://secwatch.observer/filing/0001516551-25-000002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer